XWH - 11 - 1 - 0573 TITLE : Chemical Genetic Screens for TDP - 43 Modifiers and ALS Drug Discovery

s. Vaccaro A, Kabashi E, Patten K, Aggad D, Drapeau P, Parker JA, Drug Discovery for ALS, ALS Association USA, 2012, Washington, DC, USA. Vaccaro A, Kabashi E, Patten K, Aggad D, Drapeau P, Parker JA. Chemical genetic screens for in vivo TDP-43 modifiers and ALS drug discovery. 22nd International symposium on ALS/MND, 2011. Sydney, Australia Vaccaro A, Tauffenberger A, Parker JA. Development of C. elegans models for ALS. 22nd International symposium on ALS/MND, 2011. Sydney, Australia Vaccaro A, Tauffenberger A, Parker JA. C. elegans models for ALS. International C. elegans Meeting 2011, University of California at Los Angeles, Los Angeles, California. Patten SA, Vaccaro A, Kabashi E, Parker JA, Drapeau P. Pharmacological reduction of ER stress protects against TDP-43 neuronal toxicity in vivo. Society for Neuroscience, New Orleans, LO (2012) Vaccaro A, Patten SA, Ciura S, Maios C, Therrien M, Drapeau P, Kabashi E, Parker JA. Methylene blue protects against TDP-43 and FUS neuronal toxicity in C. elegans and D. rerio. Pathology and Cellular Biology Department, University of Montreal, QC (2012) P. Drapeau and A. Parker Chemical genetic screens of TARDBP and FUS modifiers in C. elegans and zebrafish. Alzheimer’s Disease meeting, Cancun, Mexico (2012) P. Drapeau and A. Parker Chemical genetic screens of TARDBP and FUS modifiers in C. elegans and zebrafish. Keystone Conference ‘New Frontiers in Neurodegenerative Disease Research’, Santa Fe NM (2013) Patten SA, Vaccaro A, Aggad D, Maios C, Kabashi E, Parker JA, Drapeau P. Chemical genetic screens of TARDBP modifiers in C. elegans and zebrafish. 8 European Zebrafish meeting, Barcelona, Spain (2013) Patten SA,Vaccaro A, Aggad D, Kabashi E, Parker JA, Drapeau P. Chemical genetic screens of TARDBP modifiers in C. elegans and zebrafish.. Canada Association for Neuroscience, Toronto, ON (2013)